SCHEMBL13660786

SCHEMBL13660786

O=S(=O)(NC1CCc2ccccc21)c1ccc(Cl)cc1Cl

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.58
CA2 P00918 1/20 0.58
ALDH1A1 P00352 4/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
TSHR P16473 1/20 0.52
MAPK1 P28482 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
PDE4A P27815 2/20 0.51
PDE4B Q07343 2/20 0.51
PDE4C Q08493 2/20 0.51
PDE4D Q08499 2/20 0.51
FADS1 O60427 1/20 0.50
HDAC8 Q9BY41 1/20 0.47
HTT P42858 2/20 0.46
ITGA1 P56199 1/20 0.46
POLB P06746 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
KCNA5 P22460 1/20 0.45
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15915716 0.76 CA1 (0.60) CA1CA2ALDH1A1SMN1; SMN2TSHR
SCHEMBL15915670 0.76 CA1 (0.60) CA1CA2ALDH1A1SMN1; SMN2TSHR
SCHEMBL8404960 0.75 ALDH1A1 (0.69) CA1CA2ALDH1A1SMN1; SMN2TSHR
SCHEMBL2372258 0.74 HDAC8 (0.57) ALDH1A1NPSR1HDAC8HTTITGA1
SCHEMBL4759729 0.74 CA1 (1.00) CA1CA2ALDH1A1SMN1; SMN2TSHR
SCHEMBL6337843 0.74 CA1 (0.71) CA1CA2ALDH1A1SMN1; SMN2TSHR
SCHEMBL784591 0.72 CYP1A2 (0.50) CA1CA2ALDH1A1SMN1; SMN2TSHR
SCHEMBL484854 0.72 CYP1A2 (0.50) CA1CA2ALDH1A1SMN1; SMN2TSHR
SCHEMBL784576 0.72 CYP1A2 (0.50) CA1CA2ALDH1A1SMN1; SMN2TSHR
SCHEMBL786013 0.72 CYP1A2 (0.50) CA1CA2ALDH1A1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8318769-B2 Substituted sulfonamide compounds GRUENETHAL GMBH (DE) 2012-11-27 US disclosed
US-8318769-B2 Substituted sulfonamide compounds GRUENETHAL GMBH (DE) 2012-11-27 US disclosed
US-20090264400-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US disclosed
WO-2009124733-A1 SUBSTITUTED SULFONAMIDE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-10-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264400-A1 Substituted Sulfonamide Compounds BDKRB1, BDKRB2, TRPV1 CA1 1364/4885CA2 682/4885ALDH1A1 1956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.